Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients

被引:37
作者
Sato, N
Kashima, K
Tanaka, Y
Shimizu, H
Mori, M
机构
关键词
D O I
10.2337/diabetes.46.1.133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate whether granulocyte-colony stimulating factor (G-CSF) improves an impaired production of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients, we studied the effect of G-CSF on myeloperoxidase (MPO) activity and chemiluminescence amplified by a Cypridina luciferin analog (CLA-DCL), which is dependent on O-2(-) generation, and luminol (L-DCL), which is dependent on OCl- generation, in response to formyl-methonyl-leucyl-phenylalanine. Both CLA-DCL and L-DCL by neutrophils from the diabetic group (n = 15, HbA(1c) > 10%) were significantly decreased (26 and 37%, respectively: P < 0.01) compared with the age-matched normal control group (n = 15), and L-DCL was more sensitive to this inhibition than CLA-DCL (P < 0.05). In both control and diabetic neutrophils, G-CSF significantly enhanced both CLA-DCL (175% in control and 156% in diabetic) and L-DCL (283% in control and 346% in diabetic). In diabetic neutrophils, the enhancing effect of G-CSF on L-DCL was more sensitive than on CLA-DCL (P < 0.001). There was a positive correlation between HbA(1c) and the enhancing effect of G-CSF on L-DCL in diabetic patients (P < 0.05), but not on CLA-DCL. MPO activity was also decreased in the diabetic group (63%, P < 0.05), and G-CSF improved this impaired MPO activity (184%, P < 0.01). Furthermore, there was a positive correlation between HbA(1c) and the improving effect of G-CSF on MPO activity (P < 0.05). Because bacterial infection still accounts for an important cause of morbidity and mortality in diabetic patients, these data suggest that G-CSF may be useful as a drug to prevent the aggravation of bacterial infection by improving neutrophil function, especially through H2O2-MPO-OCl- mechanism, in poorly controlled diabetic patients.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 22 条
[1]  
ALTOMONTE L, 1980, IRCS MED SCI-BIOCHEM, V8, P318
[2]  
ASANO S, 1991, AM J PEDIAT HEMATOL, V13, P400
[3]   OXYGEN-DEPENDENT MICROBIAL KILLING BY PHAGOCYTES .1. [J].
BABIOR, BM .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (12) :659-668
[4]  
BALDWIN GC, 1989, BLOOD, V74, P1673
[5]  
BONILLA MA, 1989, NEW ENGL J MED, V320, P1578
[6]  
COOPPAN R, 1985, JOSLINS DIABETES MEL, P737
[7]   MYELOPEROXIDASE, A CATALYST FOR LIPOPROTEIN OXIDATION, IS EXPRESSED IN HUMAN ATHEROSCLEROTIC LESIONS [J].
DAUGHERTY, A ;
DUNN, JL ;
RATERI, DL ;
HEINECKE, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :437-444
[8]  
DECHATELET LR, 1982, J IMMUNOL, V129, P1589
[9]   Presence of hypochlorite-modified proteins in human atherosclerotic lesions [J].
Hazell, LJ ;
Arnold, L ;
Flowers, D ;
Waeg, G ;
Malle, E ;
Stocker, R .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (06) :1535-1544
[10]  
KLEBANOFF SJ, 1984, METHOD ENZYMOL, V105, P399